Simcha Therapeutics Holding Company
Latest round
- Series B
Last raised
- Jan 2022
Total raised
- $65M
Investors
- 9
About Simcha Therapeutics Holding Company
Based in Connecticut, US, and founded in 2018, Simcha Therapeutics Holding Company, LLC operates as a clinical stage immunobiology company specializing in the development of cytokine therapeutics for patients. Simcha Therapeutics Holding Company, LLC develops ST-067, which is an IL-18 cytokine that has shown potent antitumor effects in animal models, both as a monotherapy and when combined with anti-PD-1 checkpoint inhibitors. The company focuses on cytokines immunotherapies to fight cancer diseases by stimulating the immune system.
Who invested in Simcha Therapeutics Holding Company
9 investors across 2 rounds
See all investors in Simcha Therapeutics Holding Company
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Simcha Therapeutics Holding Company
Who invested in Simcha Therapeutics Holding Company?
Simcha Therapeutics Holding Company has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Simcha Therapeutics Holding Company raised?
Simcha Therapeutics Holding Company has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Simcha Therapeutics Holding Company last raise money?
Simcha Therapeutics Holding Company's most recent round on record is a Series B, in Jan 2022.
What does Simcha Therapeutics Holding Company do?
Based in Connecticut, US, and founded in 2018, Simcha Therapeutics Holding Company, LLC operates as a clinical stage immunobiology company specializing in the development of cytokine therapeutics for patients.
Where is Simcha Therapeutics Holding Company headquartered?
Simcha Therapeutics Holding Company is headquartered in New Haven, US.
Which VCs invest in companies like Simcha Therapeutics Holding Company?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Simcha Therapeutics Holding Company's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Simcha Therapeutics Holding Company? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.